New hope for head & neck cancer: drug combo trial aims to shrink tumors before surgery
NCT ID NCT07381075
Summary
This study is testing new drug combinations given to patients before surgery for advanced head and neck cancer. The goal is to see if these drugs can shrink or eliminate the tumor, potentially leading to better surgical outcomes. The trial will involve 120 patients who have not yet received any cancer treatment and are eligible for surgery. Researchers will compare three different drug regimens to see which is most effective and safe.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.